Company: PFSA
Filing Date: 2025-07-18
Form Type: 8-K
Source: 0001213900-25-065686
Chunk: 52

Company: Profusa, Inc.
Filing Date: 2025-07-18
Form: 8-K
Chunk 52
---
 of the Business Combination is described in the Proxy Statement in the section
entitled “Management of Profusa - Executive and Director Compensation of Profusa” beginning on page 262, and that information
is incorporated herein by reference.

Director Compensation

A
description of the compensation of the Company’s directors before the consummation of the Business Combination is set forth in the
Proxy Statement in the sections entitled “Management of Profusa - Executive and Director Compensation of Profusa” beginning
on page 262, and that information is incorporated herein by reference.

We
anticipate that following the Closing, the New Profusa Board will approve a non-employee director compensation program providing
for cash and equity compensation of non-employee directors.

Certain Relationships and Related Transactions

Information about certain
relationships and related party transactions is set forth in the section of the Proxy Statement entitled “Certain Relationships
and Related Person Transactions” on page 277, which information is incorporated herein by reference.

Legal Proceedings

None.

Market Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters

Information regarding holders
of the Company’s securities is set forth under “Description of the Company’s Securities” below.

Following the Closing, on
July 14, 2025, the New Profusa Common Stock began trading on Nasdaq under the symbol “PFSA.” The public units of NorthView
automatically separated into the component securities upon consummation of the Business Combination and, as a result, no longer trade
as a separate security. The public warrants continue to trade on the OTC Market under the symbol “PFSAW.”

<div align='center'>18</div>

The
Company has not paid any cash dividends on its shares of its Common Stock to date. The payment of cash dividends in the future will be
dependent upon our revenues and earnings, if any, capital requirements and general financial condition. The payment of any dividends will
be within the discretion of the Board.

Recent Sales of Unregistered Securities

Reference is made to the disclosure set forth below under Item 3.02 of this Report concerning the issuance and sale by the Company of certain unregistered securities, which is incorporated herein by reference.

Description of the Company’s Securities

The Company has authorized
305,000,000 shares of capital stock, consisting of (a) 300,000,000 shares of Common Stock, par value $0.0001 per share, and (b) 5,000,000
shares of preferred stock